Stanley Aip Gp Lp Morgan is 10% at Sagent Pharmaceuticals, Inc. (SGNT). They have made 7 open-market trades across 1 company since 2013, most recently 2015-01-23.
CIK 0001230207
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGNT | 3,225,093 | — |
Shares reported on the most recent Form 4, priced at the 2015-01-26 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGNT | SELL | 2015-01-22 | 2015-01-26 | $25.61 | $5.4M | N/A | N/A | N/A |
| SGNT | SELL | 2015-01-20 | 2015-01-22 | $25.23 | $1.7M | N/A | N/A | N/A |
| SGNT | SELL | 2015-01-15 | 2015-01-20 | $25.16 | $3.1M | N/A | N/A | N/A |
| SGNT | SELL | 2015-01-13 | 2015-01-15 | $25.51 | $2.6M | N/A | N/A | N/A |
| SGNT | SELL | 2013-10-03 | 2013-10-07 | $20.27 | $969K | N/A | N/A | N/A |
| SGNT | SELL | 2013-09-26 | 2013-09-27 | $20.37 | $1.4M | N/A | N/A | N/A |
| SGNT | SELL | 2013-09-20 | 2013-09-24 | $21.83 | $2.6M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.